Stryker launches the 1788 Advanced Imaging Platform in India

Stryker announced the launch of its 1788 Advanced Imaging Platform in India. The 1788 platform aims to deliver vibrant, 4k high-resolution images that enable surgeons to visualise critical anatomy with greater clarity. The platform features advanced fluorescence imaging capabilities, offering clearer perfusion imaging and detailed visualisation of complex anatomical structures. It is designed with the aim of use across multiple specialties. 

Aman Rishi, VP and General Manager – India, Stryker said, “Fluorescence-guided surgery is emerging as a promising solution, enabling surgeons to better visualise perfusion, tumours and critical anatomy intraoperatively.”

The 1788 platform is compatible with the currently marketed imaging agents and adaptable to new agents and fluorescence modes as they become available. The advances in this technology also enable a broader range of clinical applications and enhance additional specialties, including urology, thoracic/lungs, neurology, and ear, nose and throat.

Features of the 1788 platform include:

• Wider colour gamut for 62.5x more visible colours
• Improved fluorescence imaging with better consistency
• High dynamic range and new tone mode for more balanced lighting
• The CSF mode (Color Segmented Fluorescence) shows a colour map based on ICG intensities, especially useful for perfusion assessment and lymph node mapping. 
• The platform supports imaging agents like CYTALUX and is paired with an OLED display.